H. R. 9699
Introduced in House · July 18, 2026July 15, 2026
Ms. Chu (for herself, Ms. Castor of Florida, Ms. Lee of Pennsylvania, Mr. Pappas, Mr. Beyer, Ms. Clarke of New York, Ms. DelBene, Mr. Carson, Ms. Dexter, Mr. Doggett, Mr. Evans of Pennsylvania, Ms. Goodlander, Ms. Matsui, Ms. McCollum, Ms. Moore of Wisconsin, Mr. Mfume, Ms. Norton, Mr. Panetta, Ms. Ross, Ms. Schakowsky, Mr. Schneider, Mr. Takano, Ms. Tlaib, and Ms. Williams of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Drug Deal Disclosure Act”.